Related references
Note: Only part of the references are listed.Global research publications on systemic use of off-label and unlicensed drugs: A bibliometric analysis (1990-2020)
Waleed M. Sweileh
INTERNATIONAL JOURNAL OF RISK & SAFETY IN MEDICINE (2022)
Nonsteroidal anti-inflammatory drugs associated acute kidney injury in hospitalized children: A systematic review and meta-analysis
Jun Gong et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2022)
Off-label drugs in palliative care: a Group Delphi treatment recommendation process
Constanze Remi et al.
BMJ SUPPORTIVE & PALLIATIVE CARE (2021)
Recommendations on off-label use of intravenous azithromycin in children
Pengxiang Zhou et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)
Discordant and inappropriate discordant recommendations in consensus and evidence based guidelines: empirical analysis
Liang Yao et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Off-label use of medicines in neonates, infants, children, and adolescents: a joint policy statement by the European Academy of Paediatrics and the European society for Developmental Perinatal and Pediatric Pharmacology
Lenneke Schrier et al.
EUROPEAN JOURNAL OF PEDIATRICS (2020)
Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients
Alan Menter et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Non-steroidal Anti-inflammatory Drugs (NSAIDs) Systemic Use: The Risk of Renal Failure
Albert Bensman
FRONTIERS IN PEDIATRICS (2020)
COVID-19 and ENT Pediatric otolaryngology during the COVID-19 pandemic. Guidelines of the French Association of Pediatric Otorhinolaryngology (AFOP) and French Society of Otorhinolaryngology (SFORL)
N. Leboulanger et al.
EUROPEAN ANNALS OF OTORHINOLARYNGOLOGY-HEAD AND NECK DISEASES (2020)
Rapid advice guidelines for management of children with COVID-19
Enmei Liu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 1
Dawn M. Wahezi et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Development of the First Value Assessment Index System for Off-Label Use of Antineoplastic Agents in China: A Delphi Study
Qian Jiang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Pediatric Drug Policies Support in Safe And Effective Use Of Therapeutics In Children: A Systematic Analysis
Mary Carmack et al.
HEALTH AFFAIRS (2020)
ACMT Position Statement: Off-Label Prescribing during COVID-19 Pandemic
Andrew Stolbach et al.
JOURNAL OF MEDICAL TOXICOLOGY (2020)
Literature review informs clinical guidelines for pain management during screening and laser photocoagulation for retinopathy of prematurity
Anna Pirelli et al.
ACTA PAEDIATRICA (2019)
Guidelines for the Management of Pediatric Severe Traumatic Brain Injury, Third Edition: Update of the Brain Trauma Foundation Guidelines, Executive Summary
Patrick M. Kochanek et al.
NEUROSURGERY (2019)
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative
Seza Ozen et al.
RHEUMATOLOGY (2019)
Consistent Definitions of Clinical Practice Guidelines, Consensus Statements, Position Statements, and Practice Alerts
Girish P. Joshi et al.
ANESTHESIA AND ANALGESIA (2019)
A New Method for Ethical and Efficient Evidence Generation for Off-Label Medication Use in Oncology (A Case Study in Glioblastoma) (Publication with Expression of Concern. See vol. 14, 2023)
Samir Agrawal et al.
FRONTIERS IN PHARMACOLOGY (2019)
The ICD-11 has been adopted by the World Health Assembly
Benedetta Pocai
WORLD PSYCHIATRY (2019)
Pediatric drug development in China: Reforms and challenges
Weijia Wu et al.
PHARMACOLOGICAL RESEARCH (2019)
Clinical practice guidelines for the management of schizophrenia in children and adolescents
Sandeep Grover et al.
INDIAN JOURNAL OF PSYCHIATRY (2019)
Management of chronic urticaria in children: a clinical guideline
Carlo Caffarelli et al.
ITALIAN JOURNAL OF PEDIATRICS (2019)
Pediatric drug information available at the time of new drug approvals: A cross-sectional analysis
Joel D. Hudgins et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2018)
Consensus guidelines on the use of bisphosphonate therapy in children and adolescents
Peter J. Simm et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2018)
World Health Organization and Essential Medicines
Sagar Dugani et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents
Mona Kidon et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2018)
Postoperative pain management in children: Guidance from the pain committee of the European Society for Paediatric Anaesthesiology (ESPA Pain Management Ladder Initiative)
Maria Vittinghoff et al.
PEDIATRIC ANESTHESIA (2018)
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and Ongoing Management
Amy H. Cheung et al.
PEDIATRICS (2018)
Delays in completion and results reporting of clinical trials under the Paediatric Regulation in the European Union: A cohort study
Thomas J. Hwang et al.
PLOS MEDICINE (2018)
Conflicts of interest in infection prevention and control research: no smoke without fire. A narrative review
Mohamed Abbas et al.
INTENSIVE CARE MEDICINE (2018)
Two decades of off-label prescribing in children: a literature review
Shamala Balan et al.
WORLD JOURNAL OF PEDIATRICS (2018)
Progress in evidence-based medicine: a quarter century on
Benjamin Djulbegovic et al.
LANCET (2017)
Unlicensed and off-label uses of medicines: definitions and clarification of terminology
Jeffrey K. Aronson et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
BAP Position Statement: Off-label prescribing of psychotropic medication to children and adolescents
Aditya N. Sharma et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2016)
Association of Off-label Drug Use and Adverse Drug Events in an Adult Population
Tewodros Eguale et al.
JAMA INTERNAL MEDICINE (2016)
Rare Cancers Europe (RCE) methodological recommendations for clinical studies in rare cancers: a European consensus position paper
P. G. Casali et al.
ANNALS OF ONCOLOGY (2015)
Off-Label Use of Drugs in Children
Daniel A. C. Frattarelli et al.
PEDIATRICS (2014)
Off label use of analgesics in pediatric perioperative pain therapy from a legal perspective. Austrian interdisciplinary recommendations on pediatric perioperative pain management
M. Mayrhofer
SCHMERZ (2014)
Off-label prescribing: best practice or malpractice?
Stephen M. Stahl
CNS SPECTRUMS (2013)
GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength
Jeffrey C. Andrews et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Use of pharmaceuticals 'Off-Label' in the neonate
Joseph R. Tobin
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2010)
Off-label use of medicines: consensus recommendations for evaluating appropriateness
Allen C. Cheng et al.
MEDICAL JOURNAL OF AUSTRALIA (2007)
Classifying recommendations for clinical practice guidelines
CJ Homer et al.
PEDIATRICS (2004)
Systems for grading the quality of evidence and the strength of recommendations -: I:: Critical appraisal of existing approaches The GRADE Working Group -: art. no. 38
D Atkins et al.
BMC HEALTH SERVICES RESEARCH (2004)
Share Paper
